<table id="table_9" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 9. Bioavailability of Depakote ER Tablets Relative to Depakote When Depakote ER Dose is 8 to 20% Higher</caption>
<colgroup>
<col width="22%"></col>
<col width="26%"></col>
<col width="18%"></col>
<col width="16%"></col>
<col width="15%"></col>
</colgroup>
<thead>
<tr valign="bottom">
<td>
<br/>
<content stylecode="bold">Study Population </content>
</td>
<td align="center">
<content stylecode="bold">Regimens</content>
</td>
<td align="center" colspan="3">
<content stylecode="bold">Relative Bioavailability</content>
</td>
</tr>
<tr>
<td></td>
<td align="center">Depakote ER vs. Depakote</td>
<td align="center">AUC<sub>24</sub>
</td>
<td align="center">C<sub>max</sub>
</td>
<td align="center">C<sub>min</sub>
</td>
</tr>
</thead>
<tbody>
<tr>
<td>Healthy Volunteers (N=35)</td>
<td align="center">1000 &amp; 1500 mg<br/>Depakote ER vs.<br/>875 &amp; 1250 mg Depakote</td>
<td align="center">1.059</td>
<td align="center">0.882</td>
<td align="center">1.173</td>
</tr>
<tr>
<td>Patients with epilepsy on concomitant enzyme-inducing antiepilepsy drugs (NÂ = 64)</td>
<td align="center">1000 to 5000 mg<br/>Depakote ER vs.<br/>875 to 4250 mg<br/>Depakote</td>
<td align="center">1.008</td>
<td align="center">0.899</td>
<td align="center">1.022</td>
</tr>
</tbody>
</table>